Sorrento Gets OK For $2M Ch. 11 Funding Infusion, Asset Sale

By Emlyn Cameron · March 8, 2024, 7:56 PM EST

A Texas bankruptcy judge on Friday approved drug developer Sorrento Therapeutics Inc.'s bid for an asset sale and $2 million in funds to fuel its Chapter 11 case, saying they represented...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Agenda

Case Information

Case Title

Sorrento Therapeutics, Inc.

Case Number

Court

Texas Southern

Nature of Suit

Date Filed

February 13, 2023

Recent Articles By Emlyn

May 07, 2024
Meet The Weil Attys Guiding Steward Health's Ch. 11
April 25, 2024
3rd Circ. Lets Mallinckrodt Off Sanofi's Royalty Hook
April 10, 2024
Bankrupt Hospital Co.'s $16M Deal With Ex-Execs OK'd
April 04, 2024
Judge Denies New Official Committee In Talc Ch. 11
March 11, 2024
Judge OKs Eye Care Tech Co.'s $8M DIP Request
March 04, 2024
Sorrento Creditors Fight To Keep Ch. 11 In Texas
January 22, 2024
Mallinckrodt Trust Can Pursue Covidien Clawback Claims
December 15, 2023
Zymergen Names 2 Successful Bidders In Ch. 11 Auction
November 30, 2023
6th Circ. Says Rehab Co.'s Money Woes Justified Ch. 7 Pivot
November 17, 2023
Rite Aid Asks NJ Bankruptcy Court To Stay Ohio Opioid Case